SPI-1005 for the Treatment of Meniere's Disease (Open Label)

NCT06859788 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Meniere's Disease
Ménière's Disease

Interventions

DRUG: Ebselen

Sponsor

Sound Pharmaceuticals, Incorporated